Chemical Structure : EPIC-1042
Catalog No.: PC-25656Not For Human Use, Lab Use Only.
EPIC-1042 is a potent, small molecule PTRF/Cavin1-caveolin-1 interaction inhibitor with IC50 of 38 uM, inhibits the binding of PTRF to Caveolin-1 (CAV1), resulting in decreased secretion of small extracellular vesicles (sEVs).
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
EPIC-1042 is a potent, small molecule PTRF/Cavin1-caveolin-1 interaction inhibitor with IC50 of 38 uM, inhibits the binding of PTRF to Caveolin-1 (CAV1), resulting in decreased secretion of small extracellular vesicles (sEVs).
EPIC-1042 prevents temozolomide efflux by inhibiting small extracellular vesicles secretion, inhibits autophagy flux in the later stage.
EPIC-1042 could specifically inhibit the secretion of sEVs by disrupting the interaction between PTRF and CAV1.
EPIC-1042 inhibits autophagy flux and increase TMZ sensitivity in vivo.
EPIC-1042 could enhance TMZ efficacy in MGMT-deficient GBM tumors in vivo.
EPIC-1042 induces p62-mediated autophagic PARP1 degradation.
EPIC-1042 enhances TMZ sensitivity in MGMT-positive GBM cells.
EPIC-1042 enhances TMZ sensitivity in dose-dependent and long-term treatment manners in MGMT-deficient tumors in vivo.
| M.Wt | 350.47 | |
| Formula | C20H26N6 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Hong B, et al. Neuro Oncol. 2024 Jan 5;26(1):100-114.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright